我国皮肤科发展中几个问题的思考

1,2[]R-1[]C[]1001-7089(2001)03-0145-02,,,,1,,PCR,A()20,,,,20,,,,,20,,,,,,,,,,,,,[]1,100730;2,,,,,2,,,(),20,,,,,,,,3,,,,,,,,,,,(155)54120015153ChinJDermVenereol,May2001,Vol.15,No.3[5]HLA2A10A30+31B13B15,HLA2B13,HLA2B5,,,HLA2B5,HLA,HLA2,/HLA2B13B15,HLA2B13Schallrauter[6]HLA2BW60(40);Finco[7]HLA2B13,HLA2A30B27,,HLA2B13,,HLA2[][1]BoissyRE,LiuYY,MedranoEE,etal.Structuralaberrationoftheroughendoplasmicreticulumandmelanosomecompartmentalizationinlong2termculturesofmelanocytesfromvitiligopatients[J].JInvestDermatol,1991,97:395399[2]VenkataramMN,WhiteAG,LeenyWA,etal.HLAantigensinomanipatientswithvitiligo[J].ClinExpDermatol,1995,20(1):3537[3]AndoI,ChiHI,NakagawaH,etal.DifferenceinclinicalfeaturesandHLAantigensbetweenfamilialandnon2familialvitiligoofnon2segmen2taltype[J].BrJDermatol,1993,129(4):408411[4],,.HLA[J].,1990,23(1):3133[5],,.HLA2DRBI[J].,2000,33(1):24[6]SchallreuterKU,LevenigC,KuhnlP,etal.Histocompatibilityantigensinvitiligo:Hamburgstudyon102patientsfromnorthernGermany[J].Dermatology,1993,187(3):186192[7]FincoO,CucciaM,MartinettiG,etal.Ageofonsetinvitiligo:relation2shipwithHLAsupratypes[J].ClinicalGenetics,1991,39:4854[8].HLA[M].:,1984.126203[9].HLA[J].,1988,(4):204232[10]RoseNR.MannulofclinicallaboratoryImmunology[M].4thed.WashingtonDC:AmericansocietyforMicrobiology,1992.867876[11]MajumderPP,NovdlundJJ,NathSK.Patternoffamilialaggregationofvitiligo[J].ArchDermatol,1993,129:994996[]2000203215[]2000209220(145),,,4,,,,,,,,,,,,,20,,,,(),,,,[]2000211206[]200120122855120015153ChinJDermVenereol,May2001,Vol.15,No.3